Case 2: A 42 year-old male with a new diagnosis of diabetes mellitus. History - 1
|
|
- Bruce Marsh
- 6 years ago
- Views:
Transcription
1 Case 2: A 42 year-old male with a new diagnosis of diabetes mellitus Bruce Knutsen, MD Michael Slag, MD Lisa Thomas, RN, CDE Essentia Health Diabetes and Endocrinology Conference October 14, 2011 History - 1 JD is a 42 yr-old male, who was well and on no medications, until about 3 months ago when he started feeling fatigue and a slight increase in thirst. He lost about 10 lbs without particular effort. At the time of his employer s annual health screening he was found to have a random glucose of 220 mg/dl. Family history indicated that a grandparent on either side had adult-onset diabetes and his mother had hypothyroidism due to Hashimoto s Thyroiditis. 1
2 History - 2 Weight 210 pounds (95.4 Kg) Height 5 10 (178.3 cm) BMI 30 Blood pressure 138/88 No other significant exam findings A1c-8.2% Urine glucose - positive Does he need additional laboratory tests? 1) Electrolytes 2) Creatinine 3) Lipid Profile 4) Urine Microalbumin 5) TSH 6) A, B, and C 7) All of the above 2
3 Would any of these be helpful? 1) C-peptide 2) GAD-65 (glutamic acid decarboxylase) Ab 3) IA-2 (protein tyrosine kinase-like protein) Ab 4) Insulin antibodies 5) A and B 6) None of the above 7) All of the above What kind of Diabetes is this? 1) DM1 2) DM2 3) MODY 4) LADA 5) DM1.5 3
4 Criteria for the Diagnosis of Diabetes Mellitus A1C 6.5%. (performed in a laboratory using a NGSP certified method) or FPG 126 mg/dl (7.0 mmol/l). (ie, no caloric intake for at least 8 h) or 2-hr plasma glucose 200 mg/dl (11.1mmol/l) during an OGTT (WHO method, glucose load of 75 g glucose) or Random plasma glucose 200 mg/dl (11.1 mmol/l) in a patient with classic symptoms of hyperglycemia or hyperglycemic crisis *In the absence of unequivocal hyperglycemia, result should be confirmed by repeat testing DIABETES CARE, VOLUME 34, SUPPLEMENT 1, JANUARY 2011 Screening for and diagnosis of GDM 1 step Method 75-g OGTT with plasma glucose: fasting, 1, and 2 hrs, at weeks of gestation in women not previously diagnosed with overt diabetes. The OGTT should be performed in the morning after an overnight fast of at least 8 hrs. The diagnosis of GDM is made when any one of the following plasma glucose values are exceeded: Fasting 92 mg/dl ( 5.1 mmol/l) 1 hour 180 mg/dl (10.0 mmol/l) 2 hour 153 mg/dl ( 8.5 mmol/l) DIABETES CARE, VOLUME 34, SUPPLEMENT 1, JANUARY 2011 care.diabetesjournals.org 4
5 2 Step Testing for GDM 100-g 3hr OGTT* *2 or more thresholds must be met or exceeded Step 1 is a 50-g 1 hr loading test at weeks of gestation Glucose 1 hour later > 140 mg/dl identifies ~80% Diabetes Care 2000;23(suppl 1):S4-S19 > 130 mg/dl identifies ~90% Characteristics of Type 1, Type 2, and LADA (Latent Autoimmune Diabetes in Adults) Type 1 LADA Type 2 Typical age of onset Youth or adult Adult-Younger Adult-Older % of all diabetes ~10% ~15% ~75% Progression to insulin dependence Rapid (days/weeks) Latent (months/years) Slow (years) Presence of autoantibodies Yes (IAA, IA2, GAD) Yes (usually GAD) No Insulin dependence At diagnosis Within 6 years Over time, if at all Insulin resistance No Some Yes 5
6 Eponyms for Latent Autoimmune Diabetes in Adults Latent type 1 diabetes Latent autoimmune diabetes in adults (LADA) Slowly progressive IDDM (SPIDDM) Slow-onset IDDM Slowly progressive type 1 diabetes Type 1 1/2 diabetes LADY-like Autoimmune diabetes not requiring insulin at diagnosis LADA type 1 and type 2 Slowly progressive β-cell failure Slowly progressive adult-onset type 1 diabetes Antibody-positive phenotypic type 2 diabetes with obesity Latent autoimmune diabetes in children (LADC) doi: /diabetes.54.suppl_2.S68 Diabetes December 2005 vol. 54 no. suppl S68-S72 Differential Diagnosis of Diabetes Ab, antibody; HLA, human leukocyte antigen; LADA, latent autoimmune diabetes adult; MODY, maturity-onset diabetes of the young Melmed: Williams Textbook of Endocrinology, 12th ed 6
7 Autoantibodies Markers of Beta Cell Autoimmunity Islet Cell Antibodies (ICA), anti beta cell cytoplasmic proteins Glutamic Acid Decarboxylase Antibodies (GAD-65) Insulin Autoantibodies (IAA) IA-2A, anti-protein tyrosine phosphatase Autoantibodies against GAD 65 are found in 80% of type 1 diabetics at clinical presentation + ICA and IA-2A at diagnosis for type 1 diabetes range from 69-90% and 54-75%, respectively IAA prevalence correlates inversely with age at onset of diabetes: -usually the first marker in young children at risk for diabetes -present in ~70% of young children at time of diagnosis Shivam Champaneri, MD, and Christopher Saudek, MD, immunology/full_autoantibodies_in_type_1_diabetes.html?contentinstanceid=528535&siteid=522025#n100ea Proposed model of the pathogenesis and natural history of type 1 diabetes mellitus IAA, insulin autoantibodies; GADA, glutamic acid decarboxylase antibody; ICA, islet cell antibody; IVGTT, intravenous glucose tolerance test. (Adapted from Atkinson MA, Eisenbarth GS: Type 1 diabetes: new perspectives on disease pathogenesis and treatment, Lancet 358: , 2001.) Kliegman: Nelson Textbook of Pediatrics, 19th ed 7
8 Etiologic Classification of Diabetes Type 1 diabetes (cell destruction, usually leading to absolute insulin deficiency) A. Immune mediated B. Idiopathic Type 2 diabetes (may range from predominantly insulin resistance with relative insulin deficiency to a predominantly secretory defect with insulin resistance) Other specific types Genetic defects of -cell function MODY 1-6, Others Genetic defects in insulin action, various types of specific insulin resistance Diseases of the exocrine pancreas Endocrinopathies: Acromegaly, Cushing s, Pheochromocytoma, Hyperthyroidism, Drug or chemical induced: Nicotinic acid, Diazoxide, adrenergic agonists, Thiazides, Infections; Congenital rubella, Cytomegalovirus, Others Uncommon immune-mediated diabetes; Stiff-man syndrome, insulin receptor Ab Other genetic syndromes; Myotonic dystrophy, Prader-Willi syndrome, Others, Gestational diabetes mellitus Note** Patients with any form of diabetes may require insulin treatment at some stage of their disease. Such use of insulin does not, of itself, classify the patient. Modified from: DIABETES CARE, VOLUME 34, SUPPLEMENT 1, JANUARY 2011 S65 care.diabetesjournals.org What Course would you Predict? 1) Resolution of diabetes with weight loss 2) Long term control with Metformin 3) Rapid progression to insulin 4) Slow progression to insulin 5) Near term renal dialysis 8
9 What Initial Treatment should be Considered? 1) General Diabetes Education including nutrition and exercise 2) Metformin 3) Insulin 4) Incretin analog, Exenatide (Byetta) 5) Dipeptidyl Peptidase-4 (DPP4) inhibitor (Januvia) 6) 1 and 2 7) 2 and 4 Non-Insulin Medication Classes 9
10 Insulin Options Enter Title Text Here October 12, Cochrane Database of Systematic Reviews 2011 Interventions for latent autoimmune diabetes (LADA) in adults In summary, this review demonstrates that insulin treatment may be preferable compared to sulphonylurea treatment but there is little evidence regarding other forms of treatment. Future studies are needed, should have a clear definition of LADA, investigate patient-important outcomes and use a common method of measuring stimulated C-peptide (a marker of natural insulin production reflecting improved beta-cell function of the pancreas). Last assessed as up-to-date: December Brophy S, Davies H, Mannan S, Brunt H, Williams R. Interventions for latent autoimmune diabetes (LADA) in adults. Cochrane Database of Systematic Reviews 2011, Issue 9. Art. No.: CD DOI: / CD pub3 10
11 Initial Education Team: Patient Provider Diabetes Educator Nutrition Decrease simple sugar Consistent Carbohydrate grams for women grams for men grams for snacks Carbohydrate counting 11
12 Benefits Exercise Requires decrease insulin amounts Healthy weight Other benefits Balance Carbohydrate, Insulin and Exercise Realistic Time:150 minutes per week Ability/Motivation Blood Glucose Testing 2-4 times a day Motivation to test. Insurance driven Meter Type: Insurance driven Ease of use Coding Vision impaired Meter accuracy 15% variance Lancet Device 12
13 3 years later He has been lost to follow up and now presents with diabetic ketoacidosis and pneumonia. What happened? 1) All insulin production has ceased 2) He has stress hyperglycemia 3) He has non-diabetic ketoacidosis Should this patient be started on an Insulin Pump? 1) Yes 2) No 13
14 Insulin Pump candidate Ability Problem solving capability Carbohydrate Counting Understand risks Ketoacidosis Infection Responsible Appointments Testing Blood Glucose 4 times a day Testing Ketones Motivation Insulin Pump Candidate Unpredictable Blood Glucose Readings A1C over 7% Frequent hypoglycemia Nocturnal Hypoglycemia/ Hyperglycemia Lifestyle Career 14
15 Affordability - Insurance coverage Expensive Insurance Varies coverage % May require 3 months of blood glucose records Office notes See provider every 3 months Will patient be on Medicare at some point?? Cost Comparison Type Insulin Pump Monthly Supplies Animas Medtronic Paradigm OmniPod Accu-Chek Spirit $6345 Around $6000 $900 $6195 $ $149 $450 $151 15
16 Medicare requires: Fasting glucose and C-Peptide measurements. Fasting Glucose 225 mg/dl C-Peptide can be no greater than 110% of lowest value of the reference range Positive Autoantibody tests GAD65 Insulin Autoantibody Islet Cell autoantibody - Summary - Characteristics of LADA Adult age at diagnosis (usually over 25 years of age) Initial presentation masquerades as non-obese type 2 diabetes (does not present as diabetic ketoacidosis) Initially can be controlled with meal planning with or without diabetes oral medications Insulin dependency gradually occurs, frequently within months Positive antibodies, often GAD-65 Low C-peptide levels Unlikely to have a family history of type 2 diabetes May have a family history of other autoimmune disorders 16
17 References 1) Atkinson MA, Eisenbarth GS: Type 1 diabetes: new perspectives on disease pathogenesis and treatment, Lancet 358: , ) Brophy S, Davies H, Mannan S, Brunt H, Williams R. Interventions for latent autoimmune diabetes (LADA) in adults. Cochrane Database of Systematic Reviews 2011, Issue 9. Art. No.: CD DOI: / CD pub3 3) care.diabetesjournals.org 4) DIABETES CARE, VOLUME 34, SUPPLEMENT 1, JANUARY ) doi: /diabetes.54.suppl_2.S68 Diabetes December 2005 vol. 54 no. suppl S68-S72 6) 7) 8) 9) immunology/full_autoantibodies_in_type_1_diabetes.html?contentinstancei d=528535&siteid=522025#n100ea 10) Kliegman: Nelson Textbook of Pediatrics, 19th ed 11) Modified from: DIABETES CARE, VOLUME 34, SUPPLEMENT 1, JANUARY 2011 S65 12) Shivam Champaneri, MD, and Christopher Saudek, MD,
Janice Lazear, DNP, FNP-C, CDE DIAGNOSIS AND CLASSIFICATION OF DIABETES
Janice Lazear, DNP, FNP-C, CDE DIAGNOSIS AND CLASSIFICATION OF DIABETES Objectives u At conclusion of the lecture the participant will be able to: 1. Differentiate between the classifications of diabetes
More informationV. N. Karazin Kharkiv National University Department of internal medicine Golubkina E.O., ass. of prof., Shanina I. V., ass. of prof.
V. N. Karazin Kharkiv National University Department of internal medicine Golubkina E.O., ass. of prof., Shanina I. V., ass. of prof., Macharinskaya O.S., ass. of prof; Supervisor: prof. Yabluchanskiy
More informationWhy do we care? 20.8 million people. 70% of people with diabetes will die of cardiovascular disease. What is Diabetes?
What is Diabetes? Diabetes 101 Ginny Burns RN MEd CDE Diabetes mellitus is a group of diseases characterized by high levels of blood glucose resulting from defects in insulin production, insulin action
More informationDistinguishing T1D vs. T2D in Childhood: a case report for discussion
Distinguishing T1D vs. T2D in Childhood: a case report for discussion Alba Morales, MD Associate Professor of Pediatrics Division of Pediatric Endocrinology and Diabetes Disclosure I have no financial
More informationDiabetes mellitus - diagnosis, classification and acute complications. David Karásek 3rd Department of Internal Medicine University Hospital Olomouc
Diabetes mellitus - diagnosis, classification and acute complications David Karásek 3rd Department of Internal Medicine University Hospital Olomouc Diabetes mellitus is a group of metabolic diseases, characterized
More informationType 1 Diabetes-Pathophysiology, Diagnosis, and Long-Term Complications. Alejandro J de la Torre Pediatric Endocrinology 10/17/2014
Type 1 Diabetes-Pathophysiology, Diagnosis, and Long-Term Complications Alejandro J de la Torre Pediatric Endocrinology 10/17/2014 Objectives Understand the pathophysiology of Type 1 diabetes. Be familiar
More informationType 1 Diabetes Mellitus in the Adult. Katie Davis & Liz DeJulius KNH 411: Medical Nutrition Therapy I
Type 1 Diabetes Mellitus in the Adult Katie Davis & Liz DeJulius KNH 411: Medical Nutrition Therapy I Diabetes Mellitus: Type I Genetic factor Sudden onset Majority children and adolescents with an increasing
More informationDiabetes Mellitus in the Pediatric Patient
Diabetes Mellitus in the Pediatric Patient William Bryant, M.D. Chief of Section Pediatric Endocrinology Children s Hospital at Scott & White Texas A&M University Temple, Texas Disclosures None Definitions
More informationDiabetes: Definition Pathophysiology Treatment Goals. By Scott Magee, MD, FACE
Diabetes: Definition Pathophysiology Treatment Goals By Scott Magee, MD, FACE Disclosures No disclosures to report Definition of Diabetes Mellitus Diabetes Mellitus comprises a group of disorders characterized
More informationPart XI Type 1 Diabetes
Part XI Type 1 Diabetes Introduction Åke Lernmark Epidemiology Type 1 diabetes is increasing worldwide and shows epidemic proportions in several countries or regions [1]. There is evidence to suggest that
More informationBackground: Brief review of epidemiology, diagnosis, classification and pathophysiology of diabetes mellistus.
Insulin Therapy in Diabetes Mellitus Part 1 Lekshmi T. Nair, MD, MHS Assistant Professor Department of Internal Medicine Division of Endocrinology, Diabetes and Metabolism The Ohio State University Wexner
More informationCurrent Trends in Diagnosis and Management of Gestational Diabetes
Current Trends in Diagnosis and Management of Gestational Diabetes Shreela Mishra, MD Assistant Clinical Professor UCSF Fresno Medical Education Program 2/2/2019 Disclosures No disclosures 2/2/19 Objectives
More informationChief of Endocrinology East Orange General Hospital
Targeting the Incretins System: Can it Improve Our Ability to Treat Type 2 Diabetes? Darshi Sunderam, MD Darshi Sunderam, MD Chief of Endocrinology East Orange General Hospital Age-adjusted Percentage
More informationDIABETES MELLITUS. IAP UG Teaching slides
DIABETES MELLITUS 1 DIABETES MELLITUS IN CHILDREN Introduction, Definition Classification, pathogenesis Clinical features Investigations and diagnosis Therapy and follow up Complications Carry home message
More information1. PATHOPHYSIOLOGY OF DIABETES MELLITUS
1. PATHOPHYSIOLOGY OF DIABETES MELLITUS Prof. Vladimir Palicka, M.D., Ph.D. Institute for Clinical Biochemistry and Diagnostics, University Hospital Hradec Kralove, Czech Republic Diabetes mellitus is
More informationassociated with serious complications, but reduce occurrences with preventive measures
Wk 9. Management of Clients with Diabetes Mellitus 1. Diabetes Mellitus body s inability to metabolize carbohydrates, fats, proteins hyperglycemia associated with serious complications, but reduce occurrences
More informationYOU HAVE DIABETES. Angie O Connor Community Diabetes Nurse Specialist 25th September 2013
YOU HAVE DIABETES Angie O Connor Community Diabetes Nurse Specialist 25th September 2013 Predicated 2015 figures are already met 1 in 20 have diabetes:1in8 over 60years old Definite Diagnosis is key Early
More informationCase- history. Lab results
Neda Rasouli, M.D. Associate Professor of Medicine Division of Endocrinology, UC Denver VA_ Eastern Colorado Health Care System Case- history 46 y/o AA male with BMI 37 presented in Oct 2001 with polyuria,
More informationStandards of Medical Care in Diabetes 2016
Standards of Medical Care in Diabetes 2016 Care Delivery Systems 33-49% of patients still do not meet targets for A1C, blood pressure, or lipids. 14% meet targets for all A1C, BP, lipids, and nonsmoking
More informationDiagnosis of Diabetes
Diagnosis of Diabetes National Diabetes Information Clearinghouse U.S. Department of Health and Human Services NATIONAL INSTITUTES OF HEALTH What is diabetes? Diabetes is a disease in which levels of blood
More informationDiabetes Mellitus. Mohamed Ahmed Fouad Lecturer of Pediatrics Jazan Faculty of Medicine
Diabetes Mellitus Mohamed Ahmed Fouad Lecturer of Pediatrics Jazan Faculty of Medicine Define DM in children Differentiate types of DM Discus Etiology and Risk Factor Reason clinical presentations Set
More informationPathogenesis of Diabetes Mellitus
Pathogenesis of Diabetes Mellitus Young-Bum Kim, Ph.D. Associate Professor of Medicine Harvard Medical School Definition of Diabetes Mellitus a group of metabolic diseases characterized by hyperglycemia
More informationDiabetes Education Columbus Community Hospital Stacy Biesel RN, CDE
Diabetes Education Columbus Community Hospital Stacy Biesel RN, CDE Stacy Biesel, RN CDE Registered Nurse Certified Diabetes Educator Locations: Columbus Community Hospital Prairie Ridge Health Clinic
More informationDiabetes Update 2018: Pathogenesis of Diabetes
Diabetes Update 2018: Pathogenesis of Diabetes Katherine Lewis, MD, MSCR Assistant Professor, Endocrinology and Pediatric Endocrinology Endocrinology, Diabetes and Medical Genetics Medical University of
More information5/12/2011. Recognize the major types of diabetes: Type 2, Type 1A, Type 1B, MODY, LADA, Pancreatic diabetes, drug-induced DM
J. Christopher Lynch, Pharm.D. Professor Acting Associate Dean of Student Affairs Southern Illinois University Edwardsville School of Pharmacy The speaker has no conflicts of interest to disclose Recognize
More informationMANAGEMENT OF TYPE 1 DIABETES MELLITUS
MANAGEMENT OF TYPE 1 DIABETES MELLITUS INVESTIGATIONS AND TREATMENT MANSI NAIK VII SEMESTER INVESTIGATIONS FASTING BLOOD SUGAR PLASMA GLUCOSE HEMOGLOBIN A 1c SYMPTOMS OF TYPE 1 DIABETES MELLITUS Polyuria
More informationObjectives 10/11/2013. Diabetes- The Real Cost of Sugar. Diabetes 101: What is Diabetes. By Ruth Nekonchuk RD CDE LMNT
Diabetes- The Real Cost of Sugar By Ruth Nekonchuk RD CDE LMNT Objectives To explain diabetes To explain the risks of diabetes To enumerate the cost of diabetes to our country To enumerate the cost of
More informationEstimation of Blood Glucose level. Friday, March 7, 14
Estimation of Blood Glucose level Importance Diagnosis and treatment of carbohydrate metabolism disorders Monitor the effectivity and response to an ongoing treatment procedure Control mechanism Insulin
More informationDiabetes Mellitus (DM) - Dr Hiren Patt
Diabetes Mellitus (DM) - Dr Hiren Patt What is DM? FPG 2-Hour PG on OGTT Diabetes Mellitus Diabetes Mellitus 126 mg/dl 100 mg/dl Impaired Fasting Glucose 200 mg/dl 140 mg/dl Impaired Glucose Tolerance
More informationPrediction and Prevention of Type 1 Diabetes. How far to go?
Prediction and Prevention of Type 1 Diabetes. How far to go? Peter Colman Diabetes and Endocrinology Royal Melbourne Hospital Royal Melbourne Hospital Lancet, Saturday 30 th November 1974; p. 1279-1282
More informationCARBOHYDRATE METABOLISM Disorders
CARBOHYDRATE METABOLISM Disorders molecular formula C12H22O11 Major index which describes metabolism of carbohydrates, is a sugar level in blood. In healthy people it is 4,4-6,6 mmol/l (70-110 mg/dl)
More informationDR HJ BODANSKY MD FRCP CONSULTANT PHYSICIAN LEEDS TEACHING HOSPITALS ASSOCIATE PROFESSOR, UNIVERSITY OF LEEDS
DR HJ BODANSKY MD FRCP CONSULTANT PHYSICIAN LEEDS TEACHING HOSPITALS ASSOCIATE PROFESSOR, UNIVERSITY OF LEEDS DIABETETES UPDATE 2015 AIMS OF THE SEMINAR Diagnosis Investigation Management When to refer
More informationCommon Diabetes-related Terms
Common Diabetes-related Terms A1C An A1C test measures a person's average blood glucose level over two to three months. Hemoglobin is the part of a red blood cell that carries oxygen to the cells and sometimes
More informationCommUnityCare Women s Health Brackenridge Professional Office Building
Guidelines for Diabetes in Pregnancy Effective Date 7/1/11 *This document does not define a standard of care, nor is it intended to dictate an exclusive course of management. There are other accepted strategies
More information51 year old woman with hyperglycemia. August 9, 2012 Katie Stanley, MD
51 year old woman with hyperglycemia August 9, 2012 Katie Stanley, MD HPI Diagnosed with DM 1 year prior to visit Established primary care at that time due to notable weight loss after tobacco cessation
More informationGestational Diabetes: Long Term Metabolic Consequences. Outline 5/27/2014
Gestational Diabetes: Long Term Metabolic Consequences Gladys (Sandy) Ramos, MD Associate Clinical Professor Maternal Fetal Medicine Outline Population rates of obesity and T2DM Obesity and metabolic syndrome
More informationInsulin Pump Therapy for Type 2
9501172-011 Insulin Pump Therapy for Type 2 Objective To show the effectiveness of CSII for insulin-taking type 2 patients Key Points Tight glycemic control decreases risk of diabetes-related complications
More informationDiabetes Mellitus. What is diabetes?
Diabetes Mellitus Almost everyone knows someone who has diabetes. An estimated 23.6 million people in the United States 7.8 percent of the population have diabetes, a serious, lifelong condition. Of those,
More informationDiabetes Related Disclosures
Diabetes Related Disclosures Speakers Bureau Amylin Boehringer Ingelheim Eli Lilly Takeda Classification of Diabetes Diabetes Care January 2011 vol. 34 no. Supplement 1 S11-S61 Type 1 Diabetes Mellitus
More informationCase study: Lean adult with no complications, newly diagnosed with type 2 diabetes
Case study: Lean adult with no complications, newly diagnosed with type 2 diabetes Authored by Clifford Bailey and James LaSalle on behalf of the Global Partnership for Effective Diabetes Management. The
More informationDiabetes Mellitus, Type 1 (or Insulin-Dependent Diabetes Mellitus)
Diabetes Mellitus, Type 1 (or Insulin-Dependent Diabetes Mellitus) Pronunciations: (di"ah-be'teez MEL-ih-tus ) Diabetes Mellitus is a chronic condition characterized either by lack of insulin secretion
More information第十五章. Diabetes Mellitus
Diabetes-1/9 第十五章 Diabetes Mellitus 陳曉蓮醫師 2/9 - Diabetes 羅東博愛醫院 Management of Diabetes mellitus A. DEFINITION OF DIABETES MELLITUS Diabetes Mellitus is characterized by chronic hyperglycemia with disturbances
More informationDiabetes Mellitus. Diabetes Mellitus. Insulin. Glucose. Classifications of DM. Other glucose regulating Hormones
Diabetes Mellitus Diabetes Mellitus Pathophysiology Literally sweet urine Defined by excess blood serum glucose Normally all glucose in the PCT is reabsorbed by active transport When blood glucose is elevated,
More informationDiabetes Review. October 31, Dr. Don Eby Tracy Gaunt Dwayne Cottel
Diabetes Review October 31, 2012 Dr. Don Eby Tracy Gaunt Dwayne Cottel Diabetes Review Learning Objectives: Describe the anatomy and physiology of the pancreas Describe the effects of hormones on the maintenance
More information4. Definition and diagnostic criteria of diabetes mellitus type 1
4. Definition and diagnostic criteria of diabetes mellitus type 1 4.1. Definition of diabetes mellitus type1 Key question: What is diabetes mellitus type 1? Diabetes mellitus (DM) comprises a group of
More informationClinical Practice Guidelines for Diabetes Management
Clinical Practice Guidelines for Diabetes Management Diabetes is a disease in which blood glucose levels are above normal. Over the years, high blood glucose damages nerves and blood vessels, which can
More informationType 2 DM in Adolescents: Use of GLP-1 RA. Objectives. Scope of Problem: Obesity. Background. Pathophysiology of T2DM
Type 2 DM in Adolescents: Use of GLP-1 RA Objectives Identify patients in the pediatric population with T2DM that would potentially benefit from the use of GLP-1 RA Discuss changes in glycemic outcomes
More informationDiabetes Mellitus. Raja Nursing Instructor. Acknowledgement: Badil 09/03/2016
Diabetes Mellitus Raja Nursing Instructor 09/03/2016 Acknowledgement: Badil Objective: Define Diabetes Mellitus (DM) & types of DM. Understand the pathophysiology of Type-I & II DM. List the clinical features
More informationClinical Practice Guidelines
Clinical Practice Guidelines Diabetes Objective The purpose is to guide the appropriate diagnosis and management of Diabetes. This guideline is designed to assist the clinician by providing a framework
More informationGlycemic Control IU Health Diabetes Centers
Glycemic Control IU Health Diabetes Centers Central Nursing Orientation 3/10/2014 1 Objectives Identify laboratory results that diagnosis diabetes and reflect glycemic control Describe glycemic control
More informationStudy Code: Date: 27 July 2007
These results are supplied for informational purposes only. Prescribing decisions should be made based on the approved package insert in the country of prescription Sponsor/company: Generic drug name:
More informationSupplementary Appendix
Supplementary Appendix This appendix has been provided by the authors to give readers additional information about their work. Supplement to: Baidal DA, Ricordi C, Berman DM, et al. Bioengineering of an
More informationMae Sheikh-Ali, M.D. Assistant Professor of Medicine Division of Endocrinology University of Florida College of Medicine- Jacksonville
Mae Sheikh-Ali, M.D. Assistant Professor of Medicine Division of Endocrinology University of Florida College of Medicine- Jacksonville Pathogenesis of Diabetes Mellitus (DM) Criteria for the diagnosis
More informationNew Guidelines for the Diagnosis of Diabetes Mellitus
New Guidelines for the Diagnosis of Diabetes Mellitus Joely Straseski, PhD, DABCC, FACB Assistant Professor and Medical Director Endocrinology and Automated Core Laboratory University of Utah and ARUP
More informationVipul Lakhani, MD Oregon Medical Group Endocrinology
Vipul Lakhani, MD Oregon Medical Group Endocrinology Disclosures None Objectives Be able to diagnose diabetes and assess control Be able to identify appropriate classes of medications for diabetes treatment
More informationStandards of Care in Diabetes What's New? Veronica Brady, FNP-BC, PhD, BC-ADM,CDE Karmella Thomas, RD, LD,CDE
Standards of Care in Diabetes 2016-- What's New? Veronica Brady, FNP-BC, PhD, BC-ADM,CDE Karmella Thomas, RD, LD,CDE Terminology No longer using the term diabetic. Diabetes does not define people. People
More informationRISK FACTORS OR COMPLICATIONS AND RECOMMENDED TREATMENT GOALS AND FREQUENCY OF EVALUATION FOR ADULTS WITH DIABETES
RISK FACTORS OR COMPLICATIONS AND RECOMMENDED TREATMENT GOALS AND FREQUENCY OF EVALUATION FOR ADULTS WITH DIABETES Risk Factors or Complications Glycemic Control Fasting & Capillary Plasma Glucose Anti-platelet
More informationAUGUST 25-27, 2017 UPDATE & BOARD REVIEW. acofp INTENSIVE. Diabetes Review. Colleen Cagno, MD INNOVATIVE COMPREHENSIVE HANDS-ON
acofp INTENSIVE UPDATE & BOARD REVIEW AUGUST 25-27, 2017 Loews Chicago O'Hare Hotel Rosemont, IL INNOVATIVE COMPREHENSIVE HANDS-ON Diabetes Review Colleen Cagno, MD acofp Am eric an College of Osteopathi
More informationTreatment guideline for adult patients with type 1 diabetes?
Treatment guideline for adult patients with type 1 diabetes? Jae Hyeon Kim Division of Endocrinology and Metabolism, Samsung Medical Center, Sungkyunkwan University School of Medicine ICDM 2014 Treatment
More informationCGM Use in Pregnancy & Unique Populations ELIZABETH O. BUSCHUR, MD THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER
CGM Use in Pregnancy & Unique Populations ELIZABETH O. BUSCHUR, MD THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER Case 1: CGM use during pregnancy 29 yo G1P0000 at 10 5/7 weeks gestation presents to set
More informationDiabetes mellitus is a complex of syndromes characterized metabolically by hyperglycemia and altered glucose metabolism, and associated
Diabetes mellitus is a complex of syndromes characterized metabolically by hyperglycemia and altered glucose metabolism, and associated pathologically with specific microvascular and macrovascular complications.
More informationDiabetes in Pregnancy
Diabetes in Pregnancy Susan Drummond RN MSN C-EFM Objectives 1. Describe types of diabetes and diagnosis of gestational diabetes 2. Identify a management plan for diabetes during pregnancy 3. Describe
More informationAfter attending the lecture and reading these study notes, you will be able to:
Diabetes Mellitus Diabetes Mellitus Dr. Robyn Houlden Division of Endocrinology Queen's University Learning Objectives After attending the lecture and reading these study notes, you will be able to: State
More informationIPS Modern management of childhood diabetes mellitus
Modern management of childhood diabetes mellitus Professor Philippe LYSY, MD PhD Pediatric endocrinology and diabetology Institut de Recherche Expérimentale et Clinique Université Catholique de Louvain
More informationFor more information about how to cite these materials visit
Author(s): Arno Kumagai, M.D., 2009 License: Unless otherwise noted, this material is made available under the terms of the Creative Commons Attribution Noncommercial Share Alike 3.0 License: http://creativecommons.org/licenses/by-nc-sa/3.0/
More informationA Study on the Presence of Islets Cell Autoantibodies in Non- Insulin Requiring Young Diabetic Patients
IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 14, Issue 12 Ver. VI (Dec. 2015), PP 119-123 www.iosrjournals.org A Study on the Presence of Islets Cell
More informationDiabetes II Insulin pumps; Continuous glucose monitoring system (CGMS) Ernest Asamoah, MD FACE FACP FRCP (Lond)
Diabetes II Insulin pumps; Continuous glucose monitoring system (CGMS) Ernest Asamoah, MD FACE FACP FRCP (Lond) 9501366-011 20110401 Objectives Understand the need for insulin pumps and CGMS in managing
More informationDiabetes is usually a lifelong (chronic) disease in which there are high levels of sugar in the blood.
1 of 15 12/30/2012 10:52 PM PubMed Health. A service of the National Library of Medicine, National Institutes of Health. A.D.A.M. Medical Encyclopedia. Atlanta (GA): A.D.A.M.; 2011. Diabetes Last reviewed:
More informationClinical and Laboratory Characteristics of Childhood Diabetes Mellitus: A Single-Center Study from 2000 to 2013
Original Article www.cmj.ac.kr Clinical and Laboratory Characteristics of Childhood Diabetes Mellitus: A Single-Center Study from 2000 to 2013 Tae Hyun Park 1, Min Sun Kim 1,2, * and Dae-Yeol Lee 1,2 1
More informationVishwanath Pattan Endocrinology Wyoming Medical Center
Vishwanath Pattan Endocrinology Wyoming Medical Center Disclosure Holdings in Tandem Non for this Training Introduction In the United States, 5 to 6 percent of pregnancies almost 250,000 women are affected
More informationApplication of the Diabetes Algorithm to a Patient
Application of the Diabetes Algorithm to a Patient Apply knowledge gained from this activity to improve disease management and outcomes for patients with T2DM and obesity Note: The cases in this deck represent
More informationVITAMIN D DEFICIENCY IN TYPE 1 DIABETIC PATIENT
VITAMIN D DEFICIENCY IN TYPE 1 DIABETIC PATIENT Thesis Submitted for Fulfillment of Master Degree in Pediatrics Presented by Ahmed Mahmoud Aly Abdelaziz (M.B.B.Ch).2003 Faculty of Medicine Cairo University
More informationManagement of Type 2 Diabetes
Management of Type 2 Diabetes Pathophysiology Insulin resistance and relative insulin deficiency/ defective secretion Not immune mediated No evidence of β cell destruction Increased risk with age, obesity
More informationCourse Objectives. Diabetes Fundamentals Series Beverly Dyck Thomassian, RN, MPH, BC ADM, CDE President, Diabetes Education Services
Diabetes Fundamentals Series Beverly Dyck Thomassian, RN, MPH, BC ADM, CDE President, Diabetes Education Services 2017 Welcome to Diabetes Fundamentals Series of 6 courses designed to provide you with
More informationDIAGNOSIS OF DIABETES NOW WHAT?
DIAGNOSIS OF DIABETES NOW WHAT? DISCUSS GOALS FOR DIABETES CARE IDENTIFY COMMON COMPLIANCE- ADHERENCE ISSUES DESCRIBE TECHNOLOGY TO ASSIST AND / OR IMPROVE DIABETES CARE WHAT DO WE WANT OUR PATIENTS TO
More informationLiving Well with Diabetes
Living Well with Diabetes What is diabetes? Diabetes Overview Diabetes is a disorder of the way the body uses food for growth and energy. Most of the food people eat is broken down into glucose, the form
More informationDiabetes: Across the Lifespan Friday, October 17, Obesity, Insulin Resistance and Type 2 Diabetes Cardiovascular Risks in Children.
Diabetes: Across the Lifespan Friday, October 17, 2014 Obesity, Insulin Resistance and Type 2 Diabetes Cardiovascular Risks in Children. Don P. Wilson, M.D., FNLA Diplomate, Am Brd of Clinical Lipidology
More informationType I diabetes mellitus. Dr Laurence Lacroix
mellitus Dr Laurence Lacroix 26.03.2014 1 DEFINITION: Group of diseases characterized by a disorder of glucose homeostasis with high levels of blood glucose resulting from defects in : o insulin production
More informationIndividualizing Type 2 Diabetes Management. Cynthia Gerstenlauer, ANP-BC, GCNS-BC, CDE, CCD
Individualizing Type 2 Diabetes Management Cynthia Gerstenlauer, ANP-BC, GCNS-BC, CDE, CCD Harsh Statistics 30.3 million (9.4% of population) in US had DM in 2015 The percent of population with DM increases
More informationAbbreviations DPP-IV dipeptidyl peptidase IV DREAM Diabetes REduction Assessment with ramipril and rosiglitazone
Index Abbreviations DPP-IV dipeptidyl peptidase IV DREAM Diabetes REduction Assessment with ramipril and rosiglitazone Medication GAD glutamic acid decarboxylase GLP-1 glucagon-like peptide 1 NPH neutral
More informationThe York Diabetes Care Model
This Session The York Diabetes Care Model The annual review what s it for and how to do it How to make the diagnosis of diabetes and who to test Categorisation of diabetes at diagnosis Basics of Insulin
More informationGlucose Homeostasis. Liver. Glucose. Muscle, Fat. Pancreatic Islet. Glucose utilization. Glucose production, storage Insulin Glucagon
Glucose Homeostasis Liver Glucose Glucose utilization Glucose production, storage Insulin Glucagon Muscle, Fat Pancreatic Islet Classification of Diabetes Type 1 diabetes Type 2 diabetes Other types of
More informationReport of the Committee on the Classification and Diagnostic Criteria of Diabetes Mellitus
SPECIAL REPORT Report of the Committee on the Classification and Diagnostic Criteria of Diabetes Mellitus The Committee of the Japan Diabetes Society on the Diagnostic Criteria of Diabetes Mellitus Yutaka
More informationروش های سنجش گلوکز و ارزیابی بیماری دیابت. Dr H.R.Joshaghani PhD
روش های سنجش گلوکز و ارزیابی بیماری دیابت Dr H.R.Joshaghani PhD كربوهیدرات ها مقدمه هورمون هاي موثر در متابولیسم روشهاي اندازه گیري گلوكز هورمون هاي موثر بر متابولیسم كربوهیدرات ها انسولین گلوكاگن هورمون
More informationMonthly WellPATH Spotlight November 2016: Diabetes
Monthly WellPATH Spotlight November 2016: Diabetes DIABETES RISK FACTORS & SELF CARE TIPS Diabetes is a condition in which the body does not produce enough insulin or does not use the insulin produced
More informationLeslie K Scott PhD, PNP-BC, CDE University of Kentucky
Leslie K Scott PhD, PNP-BC, CDE University of Kentucky Review diabetes as it occurs in children Discuss the diagnosis of diabetes in children and the differentiation between type 1 and type 2 diabetes
More informationPre-diabetes. Pharmacological Approaches to Delay Progression to Diabetes
Pre-diabetes Pharmacological Approaches to Delay Progression to Diabetes Overview Definition of Pre-diabetes Risk Factors for Pre-diabetes Clinical practice guidelines for diabetes Management, including
More informationManagement of Gestational Diabetes
Management of Gestational Diabetes A Diabetes risk assessment should be ascertained at the First prenatal visit. Low Risk: Early blood glucose screening is NOT routinely required if most of the following
More informationWHEN YOUR PANCREAS IS NOT A HAPPY CAMPER A PRESENTATION ON DIABETES MANAGEMENT IN THE CAMP SETTING AMANDA COSCHI, BSCN, RN, CDE
WHEN YOUR PANCREAS IS NOT A HAPPY CAMPER A PRESENTATION ON DIABETES MANAGEMENT IN THE CAMP SETTING AMANDA COSCHI, BSCN, RN, CDE MAY 5, 2018 OBJECTIVES Strong understanding of diabetes and its management
More informationDedicated To. Course Objectives. Diabetes What is it? 2/18/2014. Managing Diabetes in the Athletic Population. Aiden
Managing Diabetes in the Athletic Population Dedicated To Aiden Michael Prybicien, LA, ATC, CSCS, CES, PES Athletic Trainer, Passaic High School Overlook Medical Center & Adjunct Faculty, William Paterson
More informationDIABETES AND PREGNANCY. CDE Exam Preparation March 22 & 27, 2018 Presented by Wendy Graham RD CDE Mentor
DIABETES AND PREGNANCY CDE Exam Preparation March 22 & 27, 2018 Presented by Wendy Graham RD CDE Mentor OBJECTIVES Describe targets for blood glucose in pregnancy Discuss the risks to baby if blood glucose
More informationHormonal Regulations Of Glucose Metabolism & DM
Hormonal Regulations Of Glucose Metabolism & DM What Hormones Regulate Metabolism? What Hormones Regulate Metabolism? Insulin Glucagon Thyroid hormones Cortisol Epinephrine Most regulation occurs in order
More informationHelpful Hints for Taking Care of Your Diabetes. Farahnaz Joarder, MD and Don Kain, MA, RD,CDE Harold Schnitzer Diabetes Health Center
Helpful Hints for Taking Care of Your Diabetes Farahnaz Joarder, MD and Don Kain, MA, RD,CDE Harold Schnitzer Diabetes Health Center Objectives How big of a problem is diabetes? What is diabetes? How is
More informationInternational Journal of Allied Medical Sciences and Clinical Research (IJAMSCR)
International Journal of Allied Medical Sciences and Clinical Research (IJAMSCR) IJAMSCR Volume 3 Issue 1 Jan-Mar- 2015 www.ijamscr.com Research article Medical research Diabetes mellitus associated mortality:
More informationDiabetes in Pregnancy
Disclosure Diabetes in Pregnancy I have no conflicts of interest to disclose Jennifer Krupp, MD Maternal Fetal Medicine St. Marys Hospital/SSM Health Madison, WI Objectives Classification of Diabetes Classifications
More informationSociety for Ambulatory Anesthesia Consensus Statement on Perioperative Blood Glucose Management in Diabetic Patients Undergoing Ambulatory Surgery
Society for Ambulatory Anesthesia Consensus Statement on Perioperative Blood Glucose Management in Diabetic Patients Undergoing Ambulatory Surgery Girish P. Joshi, MB BS, MD, FFARCSI Anesthesia & Analgesia
More informationDiabetes in Chronic Pancreatitis: When is it type 3c? Melena Bellin, MD Associate Professor, Pediatrics & Surgery Schulze Diabetes Institute
Diabetes in Chronic Pancreatitis: When is it type 3c? Melena Bellin, MD Associate Professor, Pediatrics & Surgery Schulze Diabetes Institute Disclosure Information Melena D. Bellin Disclosure of Relevant
More informationINSULIN IN THE OBESE PATIENT JACQUELINE THOMPSON RN, MAS, CDE SYSTEM DIRECTOR, DIABETES SERVICE LINE SHARP HEALTHCARE
INSULIN IN THE OBESE PATIENT JACQUELINE THOMPSON RN, MAS, CDE SYSTEM DIRECTOR, DIABETES SERVICE LINE SHARP HEALTHCARE OBJECTIVES DESCRIBE INSULIN, INCLUDING WHERE IT COMES FROM AND WHAT IT DOES STATE THAT
More informationMaximizing the Role of WIC Nutritionists in Prevention of DM2 among High Risk Clients ESTHER G. SCHUSTER, MS,RD,CDE
Maximizing the Role of WIC Nutritionists in Prevention of DM2 among High Risk Clients ESTHER G. SCHUSTER, MS,RD,CDE Heavy Numbers Surgeon General report: 68% of adults in U. S. are overweight or obese
More information